AUM Biosciences announces closing of $27Million in a “Series A” Round of funding to advance its clinical stage pipeline of precision and targeted cancer therapies
AUM Biosciences (AUM) today announced the successful completion of $27 million series A funding round. This will fuel AUM’s vision...